Bolt Biotherapeutics, Inc. Current Assets
Bolt Biotherapeutics, Inc. (BOLT) had Current Assets of $20.56 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-11
- 2026-06-30: Assets, Current $20.56M.
- 2026-03-31: Assets, Current $25.75M.
- 2025-12-31: Assets, Current $30.26M.
- 2025-09-30: Assets, Current $35.61M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $20.56M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $25.75M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $30.26M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $35.61M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $38.34M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $42.51M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $50.81M 10-K · filed 2026-03-12 |
| 2024-09-30 | $57.15M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $76.63M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $95.06M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $105.71M 10-K · filed 2025-03-24 |
| 2023-09-30 | $125.47M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $130.67M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $131.61M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $172.75M 10-K · filed 2024-03-21 |
| 2022-09-30 | $174.83M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $181.26M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $196.09M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $189.16M 10-K · filed 2023-03-29 |
| 2021-09-30 | $222.49M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $248.15M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $271.21M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $25.36M 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |